EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report

EGFR mutation testing has become an essential determination to decide treatment options for NSCLC. The mutation analysis is often conducted in samples with low percentage of tumour cells from primary tumour biopsies. There is very little evidence that samples from metastatic tissues are suitable for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamila, Wojas-Krawczyk, Michał, Skroński, Paweł, Krawczyk, Paulina, Jaguś, Tomasz, Kucharczyk, Bożena, Jarosz, Radosław, Mlak, Justyna, Szumiło, Marek, Sawicki, Trojanowski, Tomasz, Janusz, Milanowski, Joanna, Chorostowska-Wynimko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841581/
https://www.ncbi.nlm.nih.gov/pubmed/23892415
http://dx.doi.org/10.1007/s10585-013-9603-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841581/
https://www.ncbi.nlm.nih.gov/pubmed/23892415
http://dx.doi.org/10.1007/s10585-013-9603-8

Ejemplares similares